subscribeSubscribe
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU

STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU
GLOBENEWSWIRE
22 Jul 2024
Share Share
Alvotech Reports Positive Results For AVT03, Biosimilar To Prolia And Xgeva

Alvotech Reports Positive Results For AVT03, Biosimilar To Prolia And Xgeva
GLOBENEWSWIRE
02 Jul 2024
Share Share
Alvotech and STADA add to strategic alliance through denosumab partnership

Alvotech and STADA add to strategic alliance through denosumab partnership
PRESS RELEASE
12 Jun 2024
Share Share
Samsung Biosimilar Sb16 Prolia: Switching Period Results At Ects 2024

Samsung Biosimilar Sb16 Prolia: Switching Period Results At Ects 2024
GLOBENEWSWIRE
27 May 2024
Share Share
Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products

Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products
Vishnu Priyan PHARMACEUTICAL TECHNOLOGY
27 May 2024
Share Share
Henlius Xgeva® Prolia® Biosimilar: Ema Filings With Organon Validated

Henlius Xgeva® Prolia® Biosimilar: Ema Filings With Organon Validated
BUSINESSWIRE
24 May 2024
Share Share
EC approves Sandoz’s biosimilars for bone-related ailments

EC approves Sandoz’s biosimilars for bone-related ailments
PHARMACEUTICAL TECHNOLOGY
23 May 2024
Share Share
Sandoz’s Wyost and Jubbonti Granted EC Marketing Authorization

Sandoz’s Wyost and Jubbonti Granted EC Marketing Authorization
GLOBENEWSWIRE
22 May 2024
Share Share
Alvotech, Dr. Reddy`s ink pact for commercialisation of denosumab

Alvotech, Dr. Reddy`s ink pact for commercialisation of denosumab
PRESS RELEASE
21 May 2024
Share Share
MAIWEIJIAN becomes first approved biosimilar of Denosumab (120mg) in China

MAIWEIJIAN becomes first approved biosimilar of Denosumab (120mg) in China
BIOSPECTRUMASIA
09 Apr 2024
Share Share